Parabilis Medicines to present updated zolucatetide data at ESMO 2026
Parabilis Medicines said it will present updated Phase 1/2 zolucatetide data in an oral Proffered Paper session at ESMO 2026 on Oct. 24.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.